Vascular Diseases  >>  Vascana (nitroglycerin)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Vascana (nitroglycerin) / MediQuest
NCT00378521: Dose Response Study of a Topical Gel for the Treatment of Raynaud's Phenomenon

Completed
2
15
US
MQX-503
MediQuest Therapeutics
Raynaud's Disease, Raynaud's Disease Secondary to Scleroderma, Raynaud's Disease Secondary to Autoimmune Disease
 
07/06
NCT00480753: Dose Response Study of a Topical Formulation of Nitroglycerin for the Treatment of Raynaud's Phenomenon

Completed
2
15
US
Nitroglycerin
MediQuest Therapeutics
Raynaud's Disease
 
08/07

Download Options